Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Christy Rosaline Nirmal"'
Publikováno v:
Indian Journal of Health Sciences and Biomedical Research KLEU, Vol 14, Iss 3, Pp 302-309 (2021)
Multidrug resistance tuberculosis (MDR-TB) associated with the development of resistance to fluoroquinolones (FQs) especially ofloxacin is a matter of concern, as they had been earlier recommended drugs for usage in the MDR-TB treatment regimens, and
Externí odkaz:
https://doaj.org/article/054c8b607854482ea34530ff5d554dda
Autor:
Azger Dusthackeer, Shainaba A. Saadhali, Manonanthini Thangam, Sameer Hassan, Mahizhaveni Balasubramanian, Angayarkani Balasubramanian, Geetha Ramachandran, A. K. Hemanth Kumar, Kannan Thiruvenkadam, Govindarajan Shanmugam, Christy Rosaline Nirmal, Sam Ebenezer Rajadas, Sucharitha Kannappan Mohanvel, Rajesh Mondal
Publikováno v:
Frontiers in Microbiology, Vol 11 (2020)
The World Health Organization (WHO) has developed specific guidelines for critical concentrations (CCs) of antibiotics used for tuberculosis (TB) treatment, which is universally followed for drug susceptibility testing (DST) of clinical specimens. Ho
Externí odkaz:
https://doaj.org/article/d28c93fc725547d8b3a5682cc8b39bb3
Autor:
Azger Dusthackeer, Magizhaveni Balasubramanian, Govindarajan Shanmugam, Shanmuga Priya, Christy Rosaline Nirmal, Rajadas Sam Ebenezer, Angayarkanni Balasubramanian, Rajesh Kumar Mondal, Kannan Thiruvenkadam, A. K. Hemanth Kumar, Geetha Ramachandran, Selvakumar Subbian
Publikováno v:
Frontiers in Microbiology, Vol 10 (2019)
Tuberculosis (TB) remains a leading killer among infectious diseases of humans worldwide. Delayed diagnosis is a crucial problem in global TB control programs. Bacteriological methods currently used to diagnose TB in endemic countries take up to 8 we
Externí odkaz:
https://doaj.org/article/b926df4005764f7a88291b9f76891c23
Autor:
Christy Rosaline Nirmal, Sam Ebenezer Rajadas, Mahizhaveni Balasubramanian, Sucharitha Kannappan Mohanvel, Muthu Sankar Aathi, Saravanan Munishankar, Naresh Babu Chilamakuru, Kannan Thiruvenkadam, Ajith Kumar Pandiya Raj, Ramalingam Paraman, Azger Dusthackeer
Publikováno v:
Chemical Biology & Drug Design. 101:883-895
The alarming increase in multidrug resistance, which includes Bedaquiline and Delamanid, stumbles success in Tuberculosis treatment outcome. Mycobacterium tuberculosis gains resistance to rifampicin, which is one of the less toxic and potent anti-TB
Autor:
Christy Rosaline Nirmal, Sam Ebenezer Rajadas, Mahizhaveni Balasubramanian, Divya Magdaline, Naresh Babu Chilamakuru, Rajkumar Dinesh, A. Radhakrishnan, Ramalingam Paraman, Rajesh Mondal, V. N. Azger Dusthackeer
Publikováno v:
Indian Journal of Medical Research. 157:192-203
Autor:
M.R.Kamala Priya, Magizhaveni Balasubramanian, Christy Rosaline Nirmal, Azger Dusthakeer, Priya R. Iyer
Publikováno v:
Indian Journal of Tuberculosis.
Publikováno v:
New Journal of Chemistry. 44:4467-4477
Poor aqueous solubility is the major problem encountered with formulation of new bioactive chemical entities. In the present study, we report the synthesis and evaluation of inclusion complexes between two poorly water soluble antitubercular agents (
Autor:
Pasupathy Saravanan, A K Hemanthkumar, B. Mahizhaveni, Sam Ebenezer Rajadas, Srikanth Tripathy, R. S. Rajmani, Adhin Bhaskar, Geetha Ramachandran, Christy Rosaline Nirmal, Neerupma Bhardwaj, C Ponnuraja, V. N. Azger Dusthackeer
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Tuberculosis (TB) is an infectious disease caused by the bacillus Mycobacterium tuberculosis (Mtb). The present work reports the design and synthesis of a hybrid of the precursors of rifampicin and clofazimine, which led to the discovery of a novel R
Autor:
Chirom Aarti, K. Anand, E.R. Anishiya Chella Daisy, V.N. Azger Dustachkeer, Rohit Bhosale, Anil A. Chuturgoon, Mona M.M.Y. Elghandour, Ahmed El-Hussein, Shakila Harshavardhan, Nicolette N. Houreld, Murugaraj Jeyaraj, Silambuchelvi Kannayan, Ameer Khusro, Sivaraj Mehnath, K.G. Moodley, Mathew K. Moodley, Sumathra Murugan, Christy Rosaline Nirmal, Riyaz Ali M. Osmani, Vishnu Priya Padmanaban, Sarojini Jeeva Panchu, Vandana Patravale, Sam Ebenezer Rajadas, Mariappan Rajan, Pushparaju Ramasamy, Shainaba A. Saadhali, Abdelfattah Z.M. Salem, Prabakaran Selvakani, Kapil Sharma, Ekta Singh, Vignesh Sounderrajan, H.C. Swart, V. Thaver, Rudra Vaghela, K. Vijayakumar, Kevin Kumar Vijayakumar, Kandasamy Vinothini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::18e6bdb373cfcf889f5f763f46592814
https://doi.org/10.1016/b978-0-12-819985-5.09990-3
https://doi.org/10.1016/b978-0-12-819985-5.09990-3
Autor:
Sam Ebenezer Rajadas, Christy Rosaline Nirmal, Silambuchelvi Kannayan, V.N. Azger Dustachkeer, Shainaba A. Saadhali, Vishnu Priya Padmanaban
Publikováno v:
A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy ISBN: 9780128199855
Resistance to first-line and second-line antituberculosis drugs defines the terms multi- and extremely drug-resistant TB (XDR-TB), respectively. This phenomenon further hinders TB management globally and escalates the statistics with 4.1% MDR cases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4af8f25be7bf57bd21fecc2c6c8972e0
https://doi.org/10.1016/b978-0-12-819985-5.00004-8
https://doi.org/10.1016/b978-0-12-819985-5.00004-8